rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Patrick Kennedy

Director

Company insider

Files Form 4 as: Director, Jazz Pharmaceuticals.

In numbers

Trades disclosed
10
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
1 Mar 2024
Last trade
31 Aug 2026
Last filed
2 Sep 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
JAZZ Jazz PharmaceuticalsDirector · Pharmaceuticals · last 31 Aug 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
31 Aug 2026filed 2 Sep 2026JAZZ Jazz PharmaceuticalsPharmaceuticalsSEC FORM 4 Code F$3,66115 at $244.06filing
31 Aug 2026filed 2 Sep 2026JAZZ Jazz PharmaceuticalsPharmaceuticalsSEC FORM 4 Code F$444K1,840 at $241.39filing
31 Aug 2026filed 2 Sep 2026JAZZ Jazz PharmaceuticalsPharmaceuticalsSEC FORM 4 Code F$3,66115 at $244.06filing
31 Aug 2026filed 2 Sep 2026JAZZ Jazz PharmaceuticalsPharmaceuticalsSEC FORM 4 Code F$444K1,840 at $241.39filing
5 Aug 2026filed 7 Aug 2026JAZZ Jazz PharmaceuticalsPharmaceuticalsSEC FORM 4 Code A—1,605 at $0.00filing
5 Aug 2026filed 7 Aug 2026JAZZ Jazz PharmaceuticalsPharmaceuticalsSEC FORM 4 Code A—1,605 at $0.00filing
8 Aug 2025filed 11 Aug 2025JAZZ Jazz PharmaceuticalsPharmaceuticalsSEC FORM 4 Code F$218K1,959 at $111.25filing
7 Aug 2025filed 11 Aug 2025JAZZ Jazz PharmaceuticalsPharmaceuticalsSEC FORM 4 Code A—3,507 at $0.00filing
2 Aug 2024filed 6 Aug 2024JAZZ Jazz PharmaceuticalsPharmaceuticalsSEC FORM 4 Code A—3,731 at $0.00filing
1 Mar 2024filed 5 Mar 2024JAZZ Jazz PharmaceuticalsPharmaceuticalsSEC FORM 4 Code A—1,423 at $0.00filing

Sectors

No trade we could place in a sector.

Related people

Renee D. GalaPresident & CEO · President & CEO at Jazz Pharmaceuticals, filing Form 4 there in the last year
Bruce C. CozaddDirector · Director at Jazz Pharmaceuticals, filing Form 4 there in the last year
Neena M. PatilEVP & Chief Legal Officer · EVP & Chief Legal Officer at Jazz Pharmaceuticals, filing Form 4 there in the last year
Mary Elizabeth HendersonSVP, Technical Operations · SVP, Technical Operations at Jazz Pharmaceuticals, filing Form 4 there in the last year
Heather Ann McSharryDirector · Director at Jazz Pharmaceuticals, filing Form 4 there in the last year